Influence of different allelic variants of the CYP3A and ABCB1 genes on the tacrolimus pharmacokinetic profile of Chinese renal transplant recipients
about
Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patientsLack of tacrolimus circadian pharmacokinetics and CYP3A5 pharmacogenetics in the early and maintenance stages in Japanese renal transplant recipients.Pharmacogenetics as a tool for optimising drug therapy in solid-organ transplantation.Pharmacogenomics of CYP3A: considerations for HIV treatment.Importance of hematocrit for a tacrolimus target concentration strategy.Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocks.Association of CYP3A polymorphisms with the pharmacokinetics of cyclosporine A in early post-renal transplant recipients in China.Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature.Effects of Schisandra sphenanthera extract on the pharmacokinetics of tacrolimus in healthy volunteers.Impact of cytochrome P450 2C19 polymorphisms on the pharmacokinetics of tacrolimus when coadministered with voriconazole.The drug transporter ABCB1 c.3435C>T SNP influences artemether-lumefantrine treatment outcome.Effect of the P450 oxidoreductase 28 polymorphism on the pharmacokinetics of tacrolimus in Chinese healthy male volunteers.CYP3A5 genotype is associated with longer patient survival after kidney transplantation and long-term treatment with cyclosporine.
P2860
Q34065305-865DB24F-84DA-4B6C-9ADD-D43E78E0726AQ36803391-93132FEC-1A1C-4C54-B025-E3839C88624CQ36916904-23E2405D-1FB5-49C8-9A82-6CB1363FFF2FQ37419542-E4C3B5DC-654C-4229-B403-87532ACEE3A7Q37469289-199644FA-18D3-4A2D-A137-5360E12A7877Q37678060-70CDFBF0-C981-47C5-82E3-5AB1965E0D5BQ37727173-AF88F67E-9602-4FFF-A1E6-228D25F532A9Q38414396-32C3748A-9435-4228-BC50-53A2E542E73CQ39235872-2D3BDC01-FED4-48A4-9420-89AB1B6CEA3CQ41392620-27E67474-8618-42C5-A94E-603FBE9C59CCQ41693100-9F9A0DA6-0BA4-4AA3-92E3-AD6EE8456B04Q44556926-AD9894D7-D098-48F8-8BBE-219D88FFDA81Q52921101-02BC5FAC-7495-49BB-892A-255609FEDE4E
P2860
Influence of different allelic variants of the CYP3A and ABCB1 genes on the tacrolimus pharmacokinetic profile of Chinese renal transplant recipients
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Influence of different allelic ...... se renal transplant recipients
@ast
Influence of different allelic ...... se renal transplant recipients
@en
Influence of different allelic ...... se renal transplant recipients
@nl
type
label
Influence of different allelic ...... se renal transplant recipients
@ast
Influence of different allelic ...... se renal transplant recipients
@en
Influence of different allelic ...... se renal transplant recipients
@nl
prefLabel
Influence of different allelic ...... se renal transplant recipients
@ast
Influence of different allelic ...... se renal transplant recipients
@en
Influence of different allelic ...... se renal transplant recipients
@nl
P2093
P2860
P356
P1433
P1476
Influence of different allelic ...... se renal transplant recipients
@en
P2093
Chi Yuen Cheung
Chun Sang Li
Hoi Wong Chan
Johan E de Vrie
Ka Foon Chau
Kay Tai Leung
Kim Ming Wong
Marja P van Dieijen-Visser
Otto Bekers
Petal Ahm Wijnen
P2860
P304
P356
10.2217/14622416.7.4.563
P407
P577
2006-06-01T00:00:00Z